Biden says 'no time to waste' on COVID relief bill
He made brief remarks Saturday after the House passed the legislation.
This is Day 40 of the administration of President Joe Biden and Vice President Kamala Harris.
Latest headlines:
Biden's AG pick to face questions before Senate Judiciary Committee
Merrick Garland, Biden's pick for attorney general, could face tricky political questions during his confirmation hearing before the Senate Judiciary Committee today. In the wake of the Jan. 6 attack on the Capitol, Garland and Democrats are expected to point to Garland's work prosecuting the Oklahoma City bombing as evidence of his ability to investigate and prosecute domestic terrorism.
"If confirmed, I will supervise the prosecution of white supremacists and others who stormed the Capitol on January 6 – a heinous attack that sought to disrupt a cornerstone of our democracy: the peaceful transfer of power to a newly elected government,” Garland will say.
Garland's opening statement also conveys a commitment to equity, saying that upholding the Civil Rights Act remains "urgent" for the Department of Justice. Garland has received ample bipartisan support, ahead of his confirmation hearings before Senate Judiciary Monday and Tuesday, 61 former federal judges and a bipartisan group of more than 150 former Justice Department officials have penned letters in support of Garland's confirmation.
-ABC News' Alexander Mallin and Benjamin Siegel
White House 'surprised' by number of J&J vaccine doses ready to ship
The White House was surprised to discover that Johnson & Johnson will only have about 3 to 4 million doses of its vaccine ready to ship once the FDA grants an emergency use authorization, White House press secretary Jen Psaki said during a press briefing Wednesday.
Johnson & Johnson had estimated it could ship 12 million doses at the end of February in a $1 billion contract signed with the federal government in August.
“We were surprised to learn that Johnson & Johnson was behind on their manufacturing. As you noted, it was kind of reported earlier to be about 10 million, and now it's more like 3 to 4 million doses that they would be ready to ship next week if they are moved through the FDA process, which is not yet concluded, just to note," Psaki said. "And we are going to continue to work with them on ensuring that that can be expedited.”
Despite the initial availability, Johnson & Johnson has said it expects 20 million doses to be available by the end of March and to meet its contractual obligation for 100 million doses by the end of June.
-ABC News' Sarah Kolinovsky